logo
logo
SBC Medical Group Holdings Incorporated

SBC Medical Group Holdings Incorporated

NASDAQ•SBC
CEO: Dr. Yoshiyuki Aikawa
セクター: Industrials
業種: Consulting Services
上場日: 2022-09-26
SBC Medical Group Holdings Incorporated provides management services to cosmetic treatment centers in Japan, Vietnam, the United States, and internationally. The company offers advertising and marketing services; staff management services, such as recruitment and training; booking reservations for franchisee clinic customers; assistance with franchisee employee housing rentals and facility rentals; construction and design of franchisee clinics; medical equipment; and medical consumables procurement. It provides IT software solutions; breast augmentation, liposuction, and rejuvenation treatments, including treatment of wrinkles, acne, scars, cellulite, excess fat, discoloration, and signs of aging; laser skin toning and spot removal; eyes double fold surgery; rhinoplasty; treatment of osmidrosis and hyperhidrosis; hair transplants; gynecological formation treatments; laser hair removal; face line surgeries; cosmetical dental procedures; tattoo removal; lasik eye surgery; lateral canthoplasty; brow lift procedures; androgenetic alopecia treatment; and cheek sagging prevention methods. The company was founded in 2000 and is headquartered in Irvine, California.
連絡先情報
200 Spectrum Center Drive, Suite 300, Irvine, CA, 92618, United States
949-593-0250
sbc-holdings.com
時価総額
$469.80M
PER (TTM)
10.9
26.2
配当利回り
--
52週高値
$5.75
52週安値
$2.62
52週レンジ
63%
順位38Top 36.9%
4.3
F-Score
改良版 Piotroski 分析
3年ファンダメンタル
堅調 • 4.3 / 9 ポイント
スコアレンジ (0-9)
8-9: 価値が優れている
6-7: 基礎体質が強い
4-5: 全体的に堅調
0-3: パフォーマンスが弱い
データ期間: 2023-2025

財務ダッシュボード

Q3 2025 データ

売上高

$43.35M-18.33%
直近4四半期の推移

EPS

$0.12+319.13%
直近4四半期の推移

フリーCF

-$21.06M-660.30%
直近4四半期の推移

2025 Q3 決算ハイライト

主なハイライト

Q3 Net Income Surge Net income attributable to SBC was $12.82B USD for the three months ended Sep 30, 2025, marking a 352.70% increase.
Strong Cash Position Maintained Cash and cash equivalents totaled $127.43B USD as of September 30, 2025, slightly up from $125.04B USD at year-end 2024.
Rental Revenue Growth Strong Rental services revenue increased 50.79% Q3 to $6.22B USD, driven by opening new clinics and equipment demand.

リスク要因

Overall Revenue Decline Noted Total revenues for nine months fell 16.74% to $134.04B USD, primarily due to franchising fee structure revisions.
Negative Operating Cash Flow Net cash used in operating activities was $(27.30B) USD for nine months, a significant reversal from $27.89B provided in 2024.
Control Weaknesses Remain Unremediated Disclosure controls were not effective as of September 30, 2025; previously identified material weaknesses remain un-remediated.

見通し

Waqoo Acquisition Moving Forward Board approved tender offer for Waqoo, aiming for consolidation to accelerate R&D and integrate advanced technologies.
Capital Deployment Flexibility Company evaluates capital deployment options including dividends and stock repurchases while pursuing growth investments.
Ongoing Internal Control Focus Management remains committed to ongoing improvements in disclosure controls and internal control over financial reporting execution.

同業比較

売上高 (TTM)

Kelly Services, Inc.KELYA
$4.25B
-1.9%
JELD-WEN Holding, Inc.JELD
$3.21B
-14.9%
The Manitowoc Company, Inc.MTW
$2.24B
+2.9%

粗利益率 (最新四半期)

ZipRecruiter, Inc.ZIP
89.1%
-0.3pp
SBC Medical Group Holdings IncorporatedSBC
69.0%
-12.5pp
Concrete Pumping Holdings, Inc.BBCP
39.8%
-1.7pp

主要指標

銘柄コード
時価総額
PER (TTM)
ROE (TTM)
負債比率
SB$619.09M13.45.6%37.6%
ASC$571.46M18.46.4%16.3%
PANL$556.82M34.43.8%41.0%

長期トレンド

直近4四半期
売上高
純利益
営業キャッシュフロー
4四半期売上高CAGR
-0.8%
横ばい
4四半期純利益CAGR
25.2%
収益性の大幅な改善
キャッシュフロー安定性
25%
キャッシュフローに注意が必要

深度リサーチ

次回決算:2026年3月27日
|
EPS:$0.13
|
売上高:-
財務レポート
財務データ
ニュース
全年度
  • Form 10-Q - Q3 2025

    会計期末: 2025年9月30日|提出日: 2025年11月14日|
    売上高: $43.35M-18.3%
    |
    EPS: $0.12+319.1%
    予想通り
  • Form 10-Q - Q2 2025

    会計期末: 2025年6月30日|提出日: 2025年8月13日|
    売上高: $43.36M-18.3%
    |
    EPS: $0.02-87.9%
    予想を下回る
  • Form 10-Q - Q1 2025

    会計期末: 2025年3月31日|提出日: 2025年5月15日|
    売上高: $47.33M-13.6%
    |
    EPS: $0.21+4.6%
    予想通り
  • Form 10-K/A - FY 2024

    会計期末: 2024年12月31日|提出日: 2025年5月9日|
    売上高: $205.42M+6.1%
    |
    EPS: $0.48+15.5%
    予想を上回る
  • Form 10-K/A - FY 2024

    会計期末: 2024年12月31日|提出日: 2025年4月30日|修正版データを参照
  • Form 10-K - FY 2024

    会計期末: 2024年12月31日|提出日: 2025年3月28日|修正版データを参照
  • Form 10-Q - Q3 2024

    会計期末: 2024年9月30日|提出日: 2024年11月13日|
    売上高: $53.08M+12.3%
    |
    EPS: $0.03-66.4%
    予想を下回る
  • Form 10-Q - Q2 2024

    会計期末: 2024年6月30日|提出日: 2024年8月16日|
    売上高: $53.10M+29.5%
    |
    EPS: $0.20+847.8%
    不明